ENDRA Life Sciences Further Strengthens TAEUS(R) System s Intellectual Property Protection with Issuance of Two U.S. Patents
ACCESSWIRE
ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS
®), announces the Company has recently been issued U.S. Patent 10993624 (the ‘624 patent) Systems And Methods For Thermoacoustic Transducer Optimization and U.S. Patent 10996163 (the ‘163 patent) Acoustically Isolated Thermoacoustic Imaging Probe and Process of Manufacture from the United States Patent & Trademark Office (USPTO).
The TAEUS
® transducer serves to receive thermoacoustic ultrasound signals, and the 624 patent provides a tool for developing and adjusting the TAEUS
® probe and its transducer functionality to maximize the amount of information extracted from a subject.
ENDRA Life Sciences Further Strengthens TAEUS(R) System s Intellectual Property Protection with Issuance of Two U S Patents
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
PureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of Directors
April 26, 2021 GMT
PureTech Founded Entity, Gelesis, announced the appointment of marketing executive Jane Wildman to its Board of Directors. Ms. Wildman has extensive experience as a board member, president and chief marketing officer across Fortune-25, mid-sized and start-up companies. The appointment comes as Gelesis looks toward the broad United States launch of its commercial product, Plenity® this year. (Photo: Business Wire)
PureTech Founded Entity, Gelesis, announced the appointment of marketing executive Jane Wildman to its Board of Directors. Ms. Wildman has extensive experience as a board member, president and chief marketing officer across Fortune-25, mid-sized and start-up companies. The appointment comes as Gelesis looks toward the broad United States launch of its commerci
Message :
Required fields
Ms. Wildman brings extensive experience in brand building and marketing in the consumer health and wellness space, both at established market leaders and start-ups
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its Founded Entity, Gelesis, announced the appointment of marketing executive Jane Wildman to its Board of Directors. Ms. Wildman has extensive experience as a board member, president and chief marketing officer across Fortune-25, mid-sized and start-up companies. The appointment comes as Gelesis looks toward the broad United States launch of its commercial product, Plenity®, this year.
Non-alcoholic Fatty Liver Disease (NAFLD) & NASH Market Report 2021-2031 Forecasts by Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity, Other Disease Causes), by Drug Type (Vitamin E & Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cencicriviroc, Other Drug Type), by Sales Channel (Hospital Pharmacy, Online Suppliers, Retail Pharmacy, Other Sales Channel) AND Regional and Leading National Market Analysis PLUS Analysis of Leading NAFLD & NASH Companies AND COVID-19 Recovery Scenarios
April 15, 2021 10:34 ET | Source: ReportLinker ReportLinker Lyon, FRANCE
New York, April 15, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Non-alcoholic Fatty Liver Disease (NAFLD) & NASH Market Report 2021-2031 - https://www.reportlinker.com/p06061840/?utm source=GNW
vimarsana © 2020. All Rights Reserved.